H2020HORIZONFP7
Ospedale San Raffaele SRL
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 121
- As coordinator
- 49
- EU contribution (CORDIS)
- EUR 59,091,116
- Active
- 2008 to 2025
Projects
121 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| ResolVE-XASAddressing Unknowns and Unmet Needs of VEXAS Syndrome by Multiomics Clonal Tracking and Targeted Gene Editing | HORIZON | 2025 | Coordinator | EUR 1,500,000 |
| UNIONUnderstandiNg fraIlty tOwards a future of healthy ageiNg | HORIZON | 2025 | Participant | EUR 259,438 |
| ENRICHING-HDREnriching HDR edits for enhancing efficacy and precision of HSPC gene therapy | HORIZON | 2025 | Coordinator | EUR 209,483 |
| IDENTIKITIDENTIfication and tracking of cancer-prone cells in KIdney Tubules | HORIZON | 2025 | Third party | Not stated |
| TalesfromDeathDissect the impact, safety and effectiveness of gene therapy at the whole organismal level by cell-free DNA signatures | HORIZON | 2025 | Coordinator | EUR 2,000,000 |
| UniCardioMabUniversal Cardiac Mesoangioblasts for treating DMD Dilated Cardiomyopathy | HORIZON | 2025 | Coordinator | EUR 115,000 |
| LAMA2-TFIMGTackling fibrosis and inflammation in LAMA2-RD by in vivo modulation of a novel modifier gene | HORIZON | 2025 | Coordinator | EUR 172,750 |
| BAN-BOOTBoronic Acids as a New Strategy to Boost beta-Lactam Antibiotics for the Treatment of Tubercolosis | HORIZON | 2024 | Associated partner | EUR 0 |
| MOD-REGModulating Tregs in liver disease for therapeutic benefit | HORIZON | 2024 | Coordinator | EUR 188,590 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 314,289 |
| B-PathBreath Pathogen Detection (B-Path): Establishing Exhaled Breath Aerosol (XBA) sampling for diagnosis and screening of respiratory infections | HORIZON | 2024 | Participant | EUR 721,785 |
| QtCiliaA Novel Glutamine (Q) Sensory Role for Primary Cilia: Implications for Health and Disease | HORIZON | 2024 | Coordinator | EUR 2,500,000 |
| ENDEAVOREndoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrence | HORIZON | 2024 | Participant | EUR 410,573 |
| BreathForDxEstablishing Exhaled Breath Aerosol (XBA) sampling for diagnosis and screening of respiratory infections | HORIZON | 2024 | Participant | EUR 485,559 |
| PolArtNeuromorphic Polariton Accelerator | HORIZON | 2024 | Participant | EUR 143,750 |
| HSC-reNEWDissecting the molecular regulation of hematopoietic stem cell emergence using pluripotent stem cells to improve ex vivo therapies | HORIZON | 2023 | Coordinator | EUR 2,000,000 |
| REGENERATE-ITLearning from animals how to regenerate: multidisciplinary training programme in regenerative biology | HORIZON | 2023 | Participant | EUR 259,438 |
| PHIREPhotoacoustic imaging and artificial intelligence-based theranostic approach for cancer | HORIZON | 2023 | Coordinator | EUR 701,250 |
| RESTORE VISIONNovel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations | HORIZON | 2023 | Participant | EUR 1,404,906 |
| IMMUTOLADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES | HORIZON | 2023 | Third party | Not stated |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.